A trial to learn if REGN7999 is safe and well tolerated, and how it works in the body of healthy participants.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-500398-15-00

Acronym

R7999-HV-2154

Enrollment

Registered

2022-10-03

Start date

2022-10-24

Completion date

2023-08-24

Last updated

2022-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy - R7999 being developed for the treatment of diseases associated with iron overload.

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026